Info

M&A Science

M&A Science is a podcast exploring the intricate world of mergers and acquisitions with industry leaders and practitioners. With an unlimited access to our deal network, these interviews examine M&A trends, culture, and best practices. This podcast is sponsored by DealRoom, an M&A lifecycle management platform.
RSS Feed Subscribe in Apple Podcasts
M&A Science
2023
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April


2018
July
June
May
February


2017
December
September
March
February


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Jul 31, 2023

Scott Crofton, Partner at Sullivan & Cromwell LLP

This episode is sponsored by the M&A Science Academy. If you’re looking to improve your in-house training, we have corporate training plans provided.

Give your team members access to the best in class courses, templates, and networking opportunities in the industry. Our academy was designed to lead practitioners with the outdo with the M&A practices. It’s also a great way to show your support for M&A Science. 

If you’re interested in learning more about individual or team plans, visit this page.

Episode Timestamps

00:00 Intro
04:27 Mergers of equal
07:05 Managing mergers of equal
09:13 Private deals
12:55 The management team under mergers of equals
14:33 Board of directors composition
16:12 The process of mergers of equals
19:27 Diligence process
20:55 The impact of mergers of equal
23:06 Real-life story of Hostile Bids
25:13 Poison pill defense
28:51 Fairness Analysis
31:31 Litigation
33:18 Pros and Cons of Mergers of Equal
35:06 Time frame of mergers of equal
35:57 Best Advice
36:59 Craziest thing in M&A 

0 Comments
Adding comments is not available at this time.